MedTrace Logo

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

NCT00346450 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-01-13

No results posted yet for this study

Summary

To evaluate the use of cultivated conjunctival epithelial equivalents for the treatment of ocular diseases

Conditions

  • Pterygium
  • Ocular Surface Disease
  • Stevens Johnson Syndrome
  • Chemical Injury

Interventions

PROCEDURE

Cultivated conjunctival transplantation

Sponsors & Collaborators

  • International Stem Cell Forum

    collaborator OTHER

  • National Medical Research Council (NMRC), Singapore

    collaborator OTHER_GOV

  • Singapore Eye Research Institute

    collaborator OTHER

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Leonard P Ang, FRCS · SNEC, NUS

  • Donald T Tan, FRCS · SNEC, SERI, NUS

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Completion
2003-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00346450 on ClinicalTrials.gov